/Companies

Voc Diagnostics

1 known investors

Find your way into Voc Diagnostics

VOC Diagnostics develops a diagnostic method that analyzes volatile organic compounds in blood plasma samples, combined with machine learning, to detect ovarian cancer at an early stage. The company is collecting clinical evidence toward regulatory approval in the European market, with a planned launch in 2029.

Investors · 1

Frequently asked questions

What does Voc Diagnostics do?
VOC Diagnostics develops a diagnostic method that analyzes volatile organic compounds in blood plasma samples, combined with machine learning, to detect ovarian cancer at an early stage. The company is collecting clinical evidence toward regulatory approval in the European market, with a planned launch in 2029.
Who are Voc Diagnostics's investors?
Voc Diagnostics's investors include GU Ventures AB.